Online citations, reference lists, and bibliographies.
← Back to Search

Effect Of Calcitonin On The Serum Amylase Levels After Endoscopic Retrograde Cholangiopancreatography.

H. Odes, B. Novis, G. Barbezat, S. Bank
Published 1977 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Calcitonin or placebo was infused in a double-blind study in 30 patients undergoing endoscopic retrograde cholangiopancreatography. Calcitonin was found to have no significant effect on the hyperamylasemia following this procedure.



This paper is referenced by
10.1136/gut.33.8.1129
Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?
K. Binmoeller (1992)
10.1067/MGE.2002.122614
Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
S. Manolakopoulos (2002)
10.1111/j.1572-0241.1998.061_c.x
Pretreatment With Methylprednisolone to Prevent Ercp-Induced Pancreatitis: A Randomized, Multicenter, Placebo-Controlled Clinical Trial
J. Dumot (1998)
10.1016/j.curtheres.2009.08.001
Effectiveness and tolerability of NSAIDs in the prophylaxis of pancreatitis after endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis.
Minghua Zheng (2009)
10.1007/BF02973756
Effet prophylactique bénéfique de l’injection de calcitonine sur les altérations pancréatiques consécutives à la cholangiowirsungographie rétrograde
Z. Tulassay (2008)
10.1097/MPA.0000000000000090
A Meta-Analysis on the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
S. Sethi (2014)
10.1056/NEJM199609263351302
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
G. Cavallini (1996)
10.1111/apt.12534
Systematic review with network meta‐analysis: pharmacological prophylaxis against post‐ERCP pancreatitis
V. Akshintala (2013)
10.1111/j.1440-1746.2007.05096.x
Role of diclofenac in reducing post‐endoscopic retrograde cholangiopancreatography pancreatitis
M. Khoshbaten (2008)
10.1016/j.curtheres.2008.08.001
Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update.
Minghua Zheng (2008)
10.1016/j.gie.2014.06.045
Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials.
B. Kochar (2015)
Prevención de hiperamilasemia y pancreatitis posterior a la colangiopancreatografía retrógrada endoscópica con la administración rectal de indometacina
A. Loza (2006)
10.1016/S0016-5107(04)02647-1
High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.
P. Katsinelos (2005)
10.1016/S0002-9270(99)00054-4
Use of corticosteroids in the prevention of post-ERCP pancreatitis: results of a controlled prospective study
G. D. Palma (1999)
10.1016/S0016-5107(91)70620-2
The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.
Z. Tulassay (1991)
10.1097/MPA.0b013e31816857e3
Meta-Analysis of Prophylactic Allopurinol Use in Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
M. Zheng (2008)
Diclofenac versus Allopurinol for the prevention of post-ERCP pancreatitis: a prospective randomized controlled trial
Gamal A. Badra (2010)
10.4253/wjge.v2.i5.165
Endoscopic retrograde cholangiopancreatography associated pancreatitis: A 15-year review.
Kevin E. Woods (2010)
10.1186/1471-230X-8-6
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
M. Zheng (2008)
10.1016/S0002-9270(01)02461-3
Hope or hype--cytokine therapy in ERCP-induced pancreatitis.
Colm J. O'Loughlin (2001)
10.5114/pg.2020.95555
Methods for prevention of acute post-endoscopic retrograde cholangiopancreatography pancreatitis
Kamil Jaszczuk (2020)
10.1097/00006676-200307000-00018
Intraductal Administration of an NK1 Receptor Antagonist Attenuates the Inflammatory Response to Retrograde Infusion of Radiological Contrast in Rats: Implications for the Pathogenesis and Prevention of ERCP-Induced Pancreatitis
Zhi-jun He (2003)
10.1016/S0016-5085(03)00384-6
Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography.
B. Murray (2003)
10.3748/WJG.V13.I26.3567
Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.
J. Lieb (2007)
10.1007/BF01655075
A controlled trial of synthetic salmon calcitonin in the treatment of severe acute pancreatitis
E. Martínez (2005)
10.1053/BEGA.2002.0315
ERCP and MRCP--when and why.
J. Albert (2002)
10.3904/kjim.2020.069
Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis with rectal non-steroidal anti-inflammatory drugs
Tae Kwon Park (2020)
10.1016/J.DLD.2006.04.005
Pharmacological prevention of post-ERCP pancreatitis--an everlasting dream?
S. Hellmig (2006)
10.3748/wjg.v25.i29.4019
Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment
M. Pekgöz (2019)
Peut-on prévoir et prévenir la pancréatite aiguë post-CPRE ?
L. Heyries (2001)
10.1111/j.1440-1746.2003.03297.x
Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial
D. Arvanitidis (2004)
Effect of the rectal administration of indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography , and its impact on the development of secondary pancreatitis episodes
A. M. Loza (2007)
See more
Semantic Scholar Logo Some data provided by SemanticScholar